Oncocross Co., Ltd. (KOSDAQ:382150)
12,790
-1,080 (-7.79%)
At close: Dec 5, 2025
Oncocross Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 6,668 | 15,342 | 11,642 | 3,192 | 1,651 | 4,253 |
| Short-Term Investments | 18,600 | - | 5,000 | 3,000 | 3,000 | 2,003 |
| Trading Asset Securities | 1,505 | 5,409 | - | 815.93 | 9,589 | 11,524 |
| Cash & Short-Term Investments | 26,772 | 20,751 | 16,642 | 7,008 | 14,241 | 17,780 |
| Cash Growth | 105.59% | 24.69% | 137.47% | -50.79% | -19.91% | - |
| Accounts Receivable | 1.97 | 220 | - | - | - | - |
| Other Receivables | 127.2 | 12.63 | 22.69 | 4.31 | 1.61 | - |
| Receivables | 129.17 | 232.63 | 22.69 | 4.31 | 1.61 | - |
| Prepaid Expenses | 245.14 | 41.82 | 53.98 | 124.15 | 82.77 | 49.89 |
| Other Current Assets | 475.26 | 74.93 | 44.76 | 59.79 | 26.68 | 97.87 |
| Total Current Assets | 27,622 | 21,101 | 16,763 | 7,196 | 14,352 | 17,928 |
| Property, Plant & Equipment | 3,052 | 1,012 | 565.96 | 976.29 | 560.66 | 563.21 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | -0 |
| Other Intangible Assets | 52.78 | 37.85 | 47.24 | 50.62 | 57.61 | 45.54 |
| Other Long-Term Assets | 857.17 | 397.15 | 209.18 | 177.07 | 132.13 | 171.83 |
| Total Assets | 31,584 | 22,548 | 17,586 | 8,400 | 15,102 | 18,709 |
| Accrued Expenses | 103.4 | 573.36 | 558.44 | 224.35 | 191.78 | 104.17 |
| Current Portion of Leases | 277.59 | 306.33 | 115.89 | 202.41 | 69.87 | 112.18 |
| Current Income Taxes Payable | - | - | 109.86 | - | - | - |
| Other Current Liabilities | 2,549 | 968.75 | 314.81 | 1,143 | 1,547 | 16,777 |
| Total Current Liabilities | 2,930 | 1,848 | 1,099 | 1,570 | 1,809 | 16,994 |
| Long-Term Debt | 4,733 | - | - | - | 2,118 | 15,126 |
| Long-Term Leases | 68.16 | 242.61 | - | 115.89 | - | 69.87 |
| Other Long-Term Liabilities | 7,918 | - | - | 0 | - | - |
| Total Liabilities | 15,649 | 2,091 | 1,099 | 1,686 | 3,927 | 32,189 |
| Common Stock | 6,009 | 5,929 | 5,196 | 4,401 | 712.59 | 443.33 |
| Additional Paid-In Capital | 62,878 | 61,911 | 52,513 | 37,640 | 37,905 | 841.83 |
| Retained Earnings | -55,253 | -49,195 | -42,712 | -38,498 | -28,294 | -15,147 |
| Comprehensive Income & Other | 2,302 | 1,812 | 1,489 | 1,152 | 850.15 | 381.58 |
| Total Common Equity | 15,935 | 20,457 | 16,487 | 4,695 | 11,175 | -13,481 |
| Shareholders' Equity | 15,935 | 20,457 | 16,487 | 6,715 | 11,175 | -13,481 |
| Total Liabilities & Equity | 31,584 | 22,548 | 17,586 | 8,400 | 15,102 | 18,709 |
| Total Debt | 5,079 | 548.94 | 115.89 | 318.3 | 2,188 | 15,308 |
| Net Cash (Debt) | 21,693 | 20,202 | 16,526 | 6,690 | 12,052 | 2,473 |
| Net Cash Growth | 69.44% | 22.24% | 147.03% | -44.49% | 387.40% | - |
| Net Cash Per Share | 1866.40 | 1929.80 | 1854.72 | 761.64 | 2246.77 | 464.80 |
| Filing Date Shares Outstanding | 12.03 | 11.86 | 10.39 | 8.8 | 8.55 | 5.32 |
| Total Common Shares Outstanding | 12.03 | 11.86 | 10.39 | 8.8 | 8.55 | 5.32 |
| Working Capital | 24,691 | 19,252 | 15,664 | 5,627 | 12,543 | 934.4 |
| Book Value Per Share | 1325.04 | 1725.17 | 1586.45 | 533.45 | 1306.81 | -2533.95 |
| Tangible Book Value | 15,882 | 20,419 | 16,440 | 4,644 | 11,117 | -13,526 |
| Tangible Book Value Per Share | 1320.65 | 1721.98 | 1581.91 | 527.70 | 1300.07 | -2542.51 |
| Machinery | 2,323 | 90.19 | 411.85 | 737.45 | 628.31 | 383.94 |
| Construction In Progress | - | 61.02 | - | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.